Impact of FDA Updates on Public Interest in Breast Implant-associated Anaplastic Large Cell Lymphoma

In the United States, the Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, efficacy, and security of drugs, biological products, and medical devices.